Macrocephaly in Children With Autism Spectrum Disorders

Department of Educational Psychology, Baylor University, Waco, Texas 76798, USA.
Pediatric Neurology (Impact Factor: 1.7). 02/2011; 44(2):97-100. DOI: 10.1016/j.pediatrneurol.2010.09.011
Source: PubMed


Research indicates the presence of macrocephaly or abnormally large head circumferences in children with autism and spectrum-related disorders, compared with their typically developing peers. Previous research, however, centered on non-nationally representative, clinic-based samples of children and adults with autism spectrum disorders. Moreover, these samples were typically small. The present study represents results of a nationally representative, community-based sample of children with and without autism spectrum disorders, derived from the Early Childhood Longitudinal Study Birth Cohort. Results reveal statistically nonsignificant differences in the head circumferences of children with autism spectrum disorders across three time points, compared with children without autism spectrum disorders. These results may be considered highly generalizable, because they are derived from a nationally representative, community-based sample of children with and without autism spectrum disorders from the Early Childhood Longitudinal Study Birth Cohort.

42 Reads
  • Source
    • "While the studies discussed so far indicate abnormalities in HC in individuals with ASD, numerous studies have found no evidence of such differences. In a nationally representative, community-based sample of children with and without ASDs, derived from the Early Childhood Longitudinal Study Birth Cohort, Barnard-Brak et al. [73] followed about 9,000 children across three time points (9, 24, and 36 months) to see the HC growth trajectory over this time. No difference in HC at any of the three time points in the children with ASDs were found. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Despite the widely-held understanding that the biological changes that lead to autism usually occur during prenatal life, there has been relatively little research into the functional development of the brain during early infancy in individuals later diagnosed with autism spectrum disorder (ASD). This review explores the studies over the last three years which have investigated differences in various brain regions in individuals with ASD or who later go on to receive a diagnosis of ASD. We used PRISMA guidelines and selected published articles reporting any neurological abnormalities in very early childhood in individuals with or later diagnosed with ASD. Various brain regions are discussed including; the amygdala; cerebellum; frontal cortex and lateralised abnormalities of the temporal cortex during language processing. This review discusses studies investigating head circumference, electrophysiological markers and inter-hemispheric synchronisation. All the recent findings from the beginning of 2009 across these different aspects of defining neurological abnormalities are discussed in light of earlier findings. The studies across these different areas reveal the existence of atypicalities in the first year of life, well before ASD is reliably diagnosed. Cross-disciplinary approaches are essential to elucidate the pathophysiological sequence of events that lead to ASD.
    Behavioural neurology 08/2013; 2014(3). DOI:10.3233/BEN-130350 · 1.45 Impact Factor
  • Source
    • "The megalencephalic brain in autism has also been shown to have significantly more neurons than unaffected children [38]. It is important to note that megalencephaly is not specific for autism and not a requisite for diagnosis [40]. However, the temporal changes in brain size and increased number of neurons we have demonstrated following CO exposure in mice are reminiscent of features that have been reported in autism [38], [39]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Carbon monoxide (CO) exposure at high concentrations results in overt neurotoxicity. Exposure to low CO concentrations occurs commonly yet is usually sub-clinical. Infants are uniquely vulnerable to a variety of toxins, however, the effects of postnatal sub-clinical CO exposure on the developing brain are unknown. Apoptosis occurs normally within the brain during development and is critical for synaptogenesis. Here we demonstrate that brief, postnatal sub-clinical CO exposure inhibits developmental neuroapoptosis resulting in impaired learning, memory, and social behavior. Three hour exposure to 5 ppm or 100 ppm CO impaired cytochrome c release, caspase-3 activation, and apoptosis in neocortex and hippocampus of 10 day old CD-1 mice. CO increased NeuN protein, neuronal numbers, and resulted in megalencephaly. CO-exposed mice demonstrated impaired memory and learning and reduced socialization following exposure. Thus, CO-mediated inhibition of neuroapoptosis might represent an important etiology of acquired neurocognitive impairment and behavioral disorders in children.
    PLoS ONE 02/2012; 7(2):e32029. DOI:10.1371/journal.pone.0032029 · 3.23 Impact Factor
  • Source
    • "Autism was not included in the outcome definition. Autism has been found to be associated with enlarged HC in some clinical samples [28,29], but other studies, including a longitudinal evaluation of a large community-based sample, have not found an independent association [30,31]. We do not believe that identifying children who may be at minimally increased risk of autism has been, or should be, one of the goals of routine HC measurements. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The test characteristics of head circumference (HC) measurement percentile criteria for the identification of previously undetected pathology associated with head enlargement in primary care are unknown. Electronic patient records were reviewed to identify children age 3 days to 3 years with new diagnoses of intracranial expansive conditions (IEC) and metabolic and genetic conditions associated with macrocephaly (MGCM). We tested the following HC percentile threshold criteria: ever above the 95th, 97th, or 99.6th percentile and ever crossing 2, 4, or 6 increasing major percentile lines. The Centers for Disease Control and World Health Organization growth curves were used, as well as the primary care network (PCN) curves previously derived from this cohort. Among 74,428 subjects, 85 (0.11%) had a new diagnosis of IEC (n = 56) or MGCM (n = 29), and between these 2 groups, 24 received intervention. The 99.6th percentile of the PCN curve was the only threshold with a PPV over 1% (PPV 1.8%); the sensitivity of this threshold was only 15%. Test characteristics for the 95th percentiles were: sensitivity (CDC: 46%; WHO: 55%; PCN: 40%), positive predictive value (PPV: CDC: 0.3%; WHO: 0.3%; PCN: 0.4%), and likelihood ratios positive (LR+: CDC: 2.8; WHO: 2.2; PCN: 3.9). Test characteristics for the 97th percentiles were: sensitivity (CDC: 40%; WHO: 48%; PCN: 34%), PPV (CDC: 0.4%; WHO: 0.3%; PCN: 0.6%), and LR+ (CDC: 3.6; WHO: 2.7; PCN: 5.6). Test characteristics for crossing 2 increasing major percentile lines were: sensitivity (CDC: 60%; WHO: 40%; PCN: 31%), PPV (CDC: 0.2%; WHO: 0.1%; PCN: 0.2%), and LR+ (CDC: 1.3; WHO: 1.1; PCN: 1.5). Commonly used HC percentile thresholds had low sensitivity and low positive predictive value for diagnosing new pathology associated with head enlargement in children in a primary care network.
    BMC Pediatrics 01/2012; 12(1):9. DOI:10.1186/1471-2431-12-9 · 1.93 Impact Factor
Show more